James Field appears in Brel Digital’s verified company_founders attribution for LabGenius based in United Kingdom in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.
Company context (from the verified LabGenius profile): London antibody discovery company combining EVA machine-learning platform with robotic experimentation for multispecific therapeutic antibodies
Why the company matters (verified company field): LabGenius represents closed-loop biotech — its EVA platform generates antibody design hypotheses, tests them in automated wet labs, and feeds results back into models, producing lead assets like LGTX-101 Nectin-4 x CD3 T-cell engager with >70,000-fold killing selectivity cited on its pipeline page.
Official company website on file: https://labgeniustx.com. Readers should consult that site and the Sources section for primary evidence.
Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.